Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
暂无分享,去创建一个
Julian Peto | Moyses Szklo | Anthony B. Miller | Jack Cuzick | Victor Siskind | Graham A. Colditz | Chris Bain | Giske Ursin | Richard Doll | Ettore Marubini | Sylvia Richardson | Eiliv Lund | Monica Ferraroni | Emily White | Mark W. Oberle | Klim McPherson | R. J. Coates | Marilie D. Gammon | Nadine Andrieu | Janet L. Stanford | M. C. Pike | Klea Katsouyanni | D. Bull | Jonas Ranstam | Robert Spirtas | Valerie Beral | Luis Rosero-Bixby | Freda E. Alexander | Leslie Bernstein | Richard P. Gallagher | Ingemar Persson | Louise Jones | Stephen W. Duffy | K. Ebeling | R. Bergkvist | Andrew J. Coldman | Robert A. Hiatt | Kiyohiko Mabuchi | V. Beral | R. Collins | M. Pike | R. Goldbohm | C. Baines | C. Wall | B. Modan | G. Colditz | J. Ranstam | S. Duffy | J. Cuzick | R. Doll | R. Peto | R. Hiatt | R. Hoover | M. Mahoney | H. Adami | P. Wingo | E. Negri | S. Franceschi | M. Szklo | J. Stanford | A. Coldman | J. Peto | R. Coates | E. Calle | Jian-Min Yuan | R. Gallagher | H. Stalsberg | Laurence K. Kolonel | L. Brinton | I. Fentiman | R. Hanson | T. Key | K. Katsouyanni | L. Bernstein | J. Liff | A. Trichopoulou | A. Miller | C. Wongsrichanalai | P. Newcomb | R. Talamini | D. Preston | K. McPherson | F. Alexander | V. Siskind | G. Friedman | K. Mabuchi | E. White | A. Paganini-Hill | Peter Boyle | G. Ursin | C. Bain | T. Bishop | C. Schairer | C. Taylor | David B. Thomas | H. Ory | R. Haile | G. Reeves | K. Malone | Mimi C. Yu | L. Rosero-Bixby | E. Marubini | J. Hayward | E. Clarke | M. Lê | T. Möller | M. Ewertz | R. Ross | E. Lund | C. Chilvers | C. Heath | J. Daling | H. Peterson | M. Gammon | H. Wilson | I. Persson | D. Skegg | R. Spirtas | M. Rookus | L. Jones | K. Ebeling | N. Andrieu | M. Gerber | R. Renaud | H. P. Lee | L. Bergkvist | F. Levi | M. Primic‐Žakelj | D. Bull | D. Yeates | P. Kenya | D. Gatei | A. Coldman | P. Brandt | M. Oberle | C. Ségala | Fabio Levi | Rory Collins | Polly A. Newcomb | Robert W. Haile | Richard Peto | Jian-Min Yuan | Eugenia E. Calle | Jonathan M. Liff | N. Chantarakul | Suporn Koetsawang | D. Rachawat | B. Crossley | C. Hermon | Timothy J. Key | Ian S. Fentiman | Howard W. Ory | Herbert B. Peterson | P. A. Wingo | D. Kunde | P. Nishan | Tieng Pardthaisong | S. Silpisornkosol | C. Theetranont | B. Boosiri | S. Chutivongse | P. Jimakorn | Pramuan Virutamasen | C. Wongsrichanalai | Cornelia J. Baines | Hans-Olov Adami | Carle Paul | David C. G. Skegg | J. R. Daling | K. E. Malone | H. R. Cuevas | P. Ontiveros | A. Palet | S. B. Salazar | A. Cuadros | B. Gairard | J. Lansac | R. Renaud | Silvia Franceschi | Baruch Modan | Gary D. Friedman | M. Primic-Zakelj | B. Ravnihar | J. Stare | R. L. Hanson | M. C. Mahoney | P. C. Nasca | A. O. Varma | A. L. Weinstein | R. A. Goldbohm | P. A. van den Brandt | R. A. Apelo | J. Baens | J. R. de la Cruz | B. Javier | L. B. Lacaya | Mariette Gerber | C. Segala | D. Gatei | P. Kenya | A. Kungu | J. G. Mati | Louise A. Brinton | Robert N. Hoover | Catherine Schairer | Matti A. Rookus | J. A. Schoenberg | A. Neil | Dale L. Preston | CliffordR. Kay | H. Y. Wei | T. Yun | C. Zhiheng | G. Berry | J. C. Booth | T. Jelihovsky | Robert MacLennan | Q. S. Wang | H. Stalsberg | Antonia Trichopoulou | A. Dabancens | O. Salas | F. Schofield | Annlia Paganini-Hill | R. K. Ross | Marianne Ewertz | E. A. Clarke | Leif Bergkvist | S. Holck | O. Meirik | Renato Talamini | Gillian K Reeves | J. Lansac | M. Vessey | E. Noonan | F. Clavel | T. Rohan | Claus Wall | Clair Chilvers | S. Koetsawang | J. R. D. L. Cruz | R. Apelo | Clark W. Heath | A. Morabia | L. Schuman | Walter F. Stewart | P. Band | T. G. Hislop | P. Yang | Hoyt G. Wilson | Nicholas G. Martin | T. Rohan | Peter Boyle | M. Evstifeeva | E. A. Noonan | F. Clavel | L. Piana | S. R P Fine | N. Aristizabel | A. Bachelot | M. G. Lê | J. Deacon | C. N. Taylor | E. Alfandary | Elaine Ron | T. Bishop | J. Kosmelj | W. L. Beeson | Graeme Fraser | R. D. Bulbrook | J. L. Hayward | D. Y. Wang | M. C. Leske | Torgil Möller | Håkan Olsson | Corazon A. Ngelangel | M Vessey | D. Yeates | S. Jones | C. Lewis | J. Cooper Booth | R. Shearman | L. Martinez | R. Molina | B. S. Hulka | Mimi C. Yu | M. P. Longnecker | T. M N Farley | N. Chantarakul | D. Rachawat | A. Morabia | L. Schuman | W. Stewart | F. Schofield | P. Band | T. Hislop | P. Yang | A. Nomura | D. Kunde | P. Nishan | N. Martin | T. Pardthaisong | S. Silpisornkosol | C. Theetranont | B. Boosiri | S. Chutivongse | P. Jimakorn | P. Virutamasen | A. McMichael | C. Paul | G. Spears | M. Evstifeeva | W. Hutchinson | N. Weiss | A. Bràmond | B. Gairard | L. Piana | S. Fine | P. Ontiveros | A. Palet | N. Aristizabel | A. Cuadros | A. Bachelot | J. Deacon | E. Alfandary | Elaine Ron | J. Kosmelj | B. Ravnihar | J. Stare | G. Fraser | R. Bulbrook | D. Wang | P. Nasca | A. Varma | A. Weinstein | Hampus Olsson | J. Baens | B. Javier | L. Lacaya | C. Ngelangel | C. Vecchia | M. Ferraroni | S. Richardson | A. Kungu | F. V. Leeuwen | J. Schoenberg | A. Neil | M. Vessey | B. Crossley | C. Hermon | S. Jones | C. Lewis | P. Hannaford | C. Kay | H. Wei | T. Yun | C. Zhiheng | G. Berry | T. Jelihovsky | R. Maclennan | R. Shearman | A. Dabancens | L. Martínez | R. Molina | O. Salas | B. Hulka | T. Farley | S. Holck | O. Meirik | R. Bergkvist | D. Trichopoulos | LaurenceN. Kolonel | A. M Y Nomura | A. J. McMichael | G. F. S. Spears | W. B. Hutchinson | N. S. Weiss | A. Bràmond | C. La Vecchia | E. Negri | F. E. van Leeuwen | P. Hannaford | D. Trichopoulos | N. Weiss | D. Rachawat | C. L. Vecchia | D. Thomas | M. Pike | D.B. Thomas | M. Yu | P. Boyle | L. Bernstein | P. Hannaford | R. Molina | Laurence Kolonel | M. Leske | E. White | Graeme Fraser | Carle Paul | D. L. Preston | M. Longnecker | Silvia Franceschi | Louise Jones | Torgil Möller | Richard P. Gallagher | Freda E. Alexander | Anthony B. Miller | H. Adami | Eugenia E. Calle | R. J. Coates | N. Chantarakul | Suporn Koetsawang | Chris Bain | Victor Siskind | P. Band | Stephen W. Duffy | A. M. Y. Nomura | Mark W. Oberle | Herbert B. Peterson | K. Ebeling | Graham A. Colditz | C. Wongsrichanalai | A. J. McMichael | T. Rohan | David C. G. Skegg | G. F. S. Spears | Peter Boyle | W. B. Hutchinson | Nadine Andrieu | A. Bràmond | F. Clavel | J. Lansac | R. Renaud | M. G. Lê | C. N. Taylor | Baruch Modan | Gary D. Friedman | Robert A. Hiatt | T. Bishop | J. L. Hayward | D. Y. Wang | R. L. Hanson | M. C. Mahoney | A. O. Varma | Torgil Möller | E. Negri | Ettore Marubini | Mariette Gerber | C. Segala | P. Kenya | J. K. Mati | Robert N Hoover | A. Neil | Timothy J. Key | Richard Doll | CliffordR. Kay | Mimi C. Yu | R. Bergkvist | Kiyohiko Mabuchi | P. Yang | Klim McPherson | Jian-Min Yuan | Louise Jones | R. N. Hoover | G. F. Spears | J. Hayward | D. Y. Wang | R. Hoover | R. J. Coates | Chris Bain | R. Doll | A. M. Nomura | M. W. Oberle | L. Jones | A. Miller | C. Ségala | A. McMichael | G. D. Friedman | D. C. Skegg | R. P. Gallagher | N. Andrieu | P. Boyle | V. Siskind | T. Key
[1] D. Thomas,et al. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. , 1982, Journal of the National Cancer Institute.
[2] C. la Vecchia,et al. Reproductive and hormonal factors and breast cancer in a Northern Italian population. , 1985, International journal of epidemiology.
[3] B. Hulka,et al. Breast cancer and estrogen replacement therapy. , 1982, American journal of obstetrics and gynecology.
[4] R. Doll,et al. Oral contraceptives and breast cancer: final report of an epidemiological study. , 1983, British Journal of Cancer.
[5] S. Shapiro,et al. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study. , 1991, American journal of epidemiology.
[6] McMichael Aj,et al. Non-contraceptive exogenous oestrogen therapy and breast cancer , 1988 .
[7] M. Gerber,et al. The pattern of risk factors for breast cancer in a southern France population. Interest for a stratified analysis by age at diagnosis. , 1991, British Journal of Cancer.
[8] M. C. Leske,et al. Oestrogen replacement therapy and breast cancer risk: a case-control study. , 1993, International Journal of Epidemiology.
[9] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[10] R. Brownson,et al. Risk of breast cancer in relation to cigarette smoking , 1988 .
[11] N. Weiss,et al. Breast cancer among young U.S. women in relation to oral contraceptive use. , 1994, Journal of the National Cancer Institute.
[12] B. Henderson,et al. A case-control study of menopausal estrogen therapy and breast cancer. , 1980, JAMA.
[13] J. Elwood,et al. Childhood and recent eating patterns and risk of breast cancer. , 1986, Cancer detection and prevention.
[14] C. la Vecchia,et al. Non‐contraceptive oestrogens and breast cancer: An update , 1992, International journal of cancer.
[15] W. Willett,et al. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. , 1995, American journal of epidemiology.
[16] I. Fentiman,et al. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. , 1987, European journal of cancer & clinical oncology.
[17] J. Stanford,et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. , 1995, JAMA.
[18] Karen Steindorf,et al. Results of a case-control study on previous infections and other risk factors for ischemic cerebrovascular diseases: attributable and absolute risks , 1996, GMDS.
[19] L. Rosero-Bixby,et al. A case-control study of breast cancer and hormonal contraception in Costa Rica. , 1987, Journal of the National Cancer Institute.
[20] R. Hoover,et al. Oral contraceptives and breast cancer risk among younger women. , 1995, Journal of the National Cancer Institute.
[21] M. Goodman,et al. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. , 1997, Preventive medicine.
[22] R. Hoover,et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. , 1989, The New England journal of medicine.
[23] S. Shapiro,et al. Noncontraceptive estrogen use and the risk of breast cancer. , 1984, JAMA.
[24] M. C. Leske,et al. Breast cancer and hormonal contraceptives: further results , 1996 .
[25] T. Sellers,et al. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. , 1995, American journal of public health.
[26] R. Hoover,et al. Conjugated estrogens and breast cancer risk in women. , 1981, Journal of the National Cancer Institute.
[27] J. Tonascia,et al. Exogenous hormones, reproductive history, and breast cancer. , 1977, Journal of the National Cancer Institute.
[28] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[29] K. McPherson,et al. Oral contraceptives and breast cancer: latest findings in a large cohort study. , 1989, British Journal of Cancer.
[30] J. Kelsey,et al. Exogenous estrogens and other factors in the epidemiology of breast cancer. , 1981, Journal of the National Cancer Institute.
[31] R. Hiatt,et al. Exogenous estrogen and breast cancer after bilateral oophorectomy , 1984, Cancer.
[32] M. Szklo,et al. Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls. , 1993, Preventive medicine.
[33] W. L. Beeson,et al. Prospective study of exogenous hormone use and breast cancer in seventh‐day adventists , 1989, Cancer.
[34] L. Kolonel,et al. The association of replacement estrogens with breast cancer , 1986, International journal of cancer.
[35] A G Babiker,et al. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.
[36] P. Wingo,et al. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. , 1987, JAMA.
[37] G A Colditz,et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.
[38] W. Thompson,et al. Oral Contraceptives and Premenopausal Bilateral Breast Cancer: A Case-Control Study , 1992, Epidemiology.
[39] R. Hoover,et al. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. , 1996, Journal of the National Cancer Institute.
[40] A. Huggins,et al. Risk factors for breast cancer with applications to selection for the prevalence screen. , 1987, Journal of epidemiology and community health.
[41] K. Namboodiri,et al. Breast Cancer Risk: Effects of Estrogen Replacement Therapy and Body Mass , 1992 .
[42] B. Sherman,et al. Estrogen use and breast cancer interaction with body mass , 1983, Cancer.
[43] S. Stellman,et al. The epidemiology of breast cancer in 785 united states caucasian women , 1978, Cancer.
[44] C Bain,et al. Breast cancer and breastfeeding: results from an Australian case-control study. , 1989, American journal of epidemiology.
[45] F. Levi,et al. Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[46] U. Pastorino,et al. The relationship of dietary intake and serum levels of retinol and beta‐carotene with breast cancer. Results of a case‐control study , 1988, Cancer.
[47] K. Kosmelj,et al. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. , 1988, Neoplasma.
[48] R. Hoover,et al. Menopausal estrogen use and risk of breast cancer , 1981, Cancer.
[49] The Who Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and combined oral contraceptives: results from a multinational study , 1990 .
[50] J. Lindtner,et al. An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. , 1979, European journal of cancer.
[51] C. Paul,et al. Oral contraceptives and risk of breast cancer , 1990, International journal of cancer.
[52] A. Miller,et al. Canadian National Breast Screening Study. , 1990, AJR. American journal of roentgenology.
[53] R. Doll,et al. Early oral contraceptive use and breast cancer: results of another case-control study. , 1987, British Journal of Cancer.
[54] Julian Peto,et al. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.
[55] P. Hannaford,et al. Breast cancer and the pill--a further report from the Royal College of General Practitioners' oral contraception study. , 1988, British Journal of Cancer.
[56] S. Shapiro,et al. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. , 1991 .
[57] S. Hankinson,et al. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: A case‐control study in greece , 1995, International journal of cancer.
[58] F. Leeuwen,et al. Oral contraceptives and risk of breast cancer in women aged 20-54 years , 1994, The Lancet.
[59] R. Horwitz,et al. Effect of clinical features on the association of estrogens and breast cancer. , 1984, The American journal of medicine.
[60] O. Nanni,et al. Hormone replacement treatment and breast cancer risk: a cooperative Italian study. , 1995, British Journal of Cancer.
[61] M. Ewertz. Influence of non‐contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark , 1988, International journal of cancer.